SANUWAVE Health, Inc. (SNWV)
Nasdaq · Healthcare · Medical Devices
$4.70−2.49%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $40.4M
- P/E (trailing)
- 19.6
- 52-week range
- $3.92 – $36.42
- 52-week change
- −84.94%
- EPS (trailing)
- $0.24
- Next earnings
- Nov 6, 2026
Fiscal year to Dec 2025
- Revenue
- $44.1M (+34.98%)
- Net income
- $11.8M
- Operating margin
- 11.2%
- Diluted EPS
- $0.41
- Free cash flow
- $1.9M
From the company’s annual report on SEC EDGAR.
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Headquarters: Eden Prairie, United States · 55 employees · sanuwave.com